Citation: M. Samal et al., RELATIVE RENAL UPTAKE AND TRANSIT-TIME MEASUREMENTS USING FUNCTIONAL FACTOR IMAGES AND FUZZY REGIONS OF INTEREST, European journal of nuclear medicine, 25(1), 1998, pp. 48-54
Authors:
KUIKKA JT
BRITTON KE
CHENGAZI VU
SAVOLAINEN S
Citation: Jt. Kuikka et al., FUTURE-DEVELOPMENTS IN NUCLEAR-MEDICINE INSTRUMENTATION - A REVIEW, Nuclear medicine communications, 19(1), 1998, pp. 3-12
Authors:
HALL AV
SOLANKI KK
VINJAMURI S
BRITTON KE
DAS SS
Citation: Av. Hall et al., EVALUATION OF THE EFFICACY OF TC-99M-INFECTON, A NOVEL AGENT FOR DETECTING SITES OF INFECTION, Journal of Clinical Pathology, 51(3), 1998, pp. 215-219
Authors:
BIASSONI L
GRANOWSKA M
CARROLL MJ
MATHER SJ
HOWELL R
ELLISON D
MACNEILL FA
WELLS CA
CARPENTER R
BRITTON KE
Citation: L. Biassoni et al., TC-99M-LABELED SM3 IN THE PREOPERATIVE EVALUATION OF AXILLARY LYMPH-NODES AND PRIMARY BREAST-CANCER WITH CHANGE DETECTION STATISTICAL PROCESSING AS AN AID TO TUMOR-DETECTION, British Journal of Cancer, 77(1), 1998, pp. 131-138
Authors:
CHESSER AMS
CARROLL MC
LIGHTOWLER C
MACDOUGALL IC
BRITTON KE
BAKER LRI
Citation: Ams. Chesser et al., TC-99M METHOXY ISOBUTYL ISONITRILE (MIBI) IMAGING OF THE PARATHYROID-GLANDS IN PATIENTS WITH RENAL-FAILURE, Nephrology, dialysis, transplantation, 12(1), 1997, pp. 97-100
Authors:
STALTERI MA
MATHER SJ
BELINKA BA
COUGHLIN DJ
CHENGAZI VU
BRITTON KE
Citation: Ma. Stalteri et al., SITE-SPECIFIC CONJUGATION AND LABELING OF PROSTATE ANTIBODY 7E11C5.3 (CYT-351) WITH TC-99M, European journal of nuclear medicine, 24(6), 1997, pp. 651-654
Authors:
BRITTON KE
VINJAMURI S
HALL AV
SOLANKI K
SIRAJ QH
BOMANJI J
DAS S
Citation: Ke. Britton et al., CLINICAL-EVALUATION OF TC-99M INFECTION FOR THE LOCALIZATION OF BACTERIAL-INFECTION, European journal of nuclear medicine, 24(5), 1997, pp. 553-556
Citation: Mj. Carroll et Ke. Britton, OPTIMIZED STATISTICAL DETECTION, OSD, OF MULTIPLE PARATHYROID-GLAND HYPERPLASIA MPGH, The Journal of nuclear medicine, 38(5), 1997, pp. 616-616
Authors:
CHENGAZI VU
FENELEY MR
ELLISON D
STALTERI M
GRANOWSKI A
GRANOWSKA M
NIMMON CC
MATHER SJ
KIRBY RS
BRITTON KE
Citation: Vu. Chengazi et al., IMAGING PROSTATE-CANCER WITH TECHNETIUM-99M-7E11-C5.3 (CYT-351), The Journal of nuclear medicine, 38(5), 1997, pp. 675-682
Authors:
GOLDBERG PA
KAMM MA
NICHOLLS RJ
MORRIS G
BRITTON KE
Citation: Pa. Goldberg et al., CONTRIBUTION OF GASTROINTESTINAL TRANSIT AND POUCH CHARACTERISTICS INDETERMINING POUCH FUNCTION, Gut, 40(6), 1997, pp. 790-793
Citation: Ke. Britton, POSITIVE MIBG SCANNING AT THE TIME OF RELAPSE IN NEUROBLASTOMA WHICH WAS MIBG NEGATIVE AT DIAGNOSIS .1., British journal of radiology, 70(837), 1997, pp. 969-969
Authors:
NERI D
PETRUL H
WINTER G
LIGHT Y
MARAIS R
BRITTON KE
CREIGHTON AM
Citation: D. Neri et al., RADIOACTIVE LABELING OF RECOMBINANT ANTIBODY FRAGMENTS BY PHOSPHORYLATION USING HUMAN CASEIN KINASE-II AND [GAMMA-P-32]-ATP, Nature biotechnology, 14(4), 1996, pp. 485-490
Authors:
GAUSDEN E
ARMOUR JAL
COYLE B
COFFEY R
HOCHBERG Z
PEMBREY M
BRITTON KE
GROSSMAN A
REARDON W
TREMBATH R
Citation: E. Gausden et al., THYROID PEROXIDASE - EVIDENCE FOR DISEASE GENE EXCLUSION IN PENDREDS-SYNDROME, Clinical endocrinology, 44(4), 1996, pp. 441-446
Authors:
STALTERI MA
MATHER SJ
CHENGAZI V
GRANOWSKA M
KIRBY RJ
FENELEY M
BRITTON KE
Citation: Ma. Stalteri et al., TECHNETIUM-LABELED PROSTATE ANTIBODY 7E11C5.3 (CYT-351)-CONJUGATION, LABELING AND CLINICAL-STUDIES, The Journal of nuclear medicine, 37(5), 1996, pp. 375-375